Preview

FARMAKOEKONOMIKA. Modern Pharmacoeconomics and Pharmacoepidemiology

Advanced search

Search


Order results by:     
 
Issue Title
 
Vol 9, No 3 (2016) COPAYMENTS OF THE CITIZENS IN HEALTHCARE SYSTEM: INTERNATIONAL PRACTICE Abstract  similar documents
A. P. Tatarinov, D. V. Lukyantseva, L. S. Melnikova, V. V. Omelyanovskii
"... The growth of cost of healthcare services becomes more and more serious problem throughout ..."
 
Vol 17, No 3 (2024) Economic analysis of implementing Systemic Coronary Risk Estimation (SCORE2) scale and long-term consequences Abstract  similar documents
E. O. Kurilovich, A. V. Nikitina, I. V. Sorokovikov
"... analysis of long-term consequences involved calculating the cost of pharmacotherapy and the costs ..."
 
Vol 11, No 3 (2018) Determination of a willingness-to-pay threshold and decision-making in financing the healthcare technologies Abstract  similar documents
T. S. Teptsova, T. P. Bezdenezhnyh, V. K. Fedyaeva, N. Z Musina, G. R. Hachatryan, V. V. Tarasov
"... outcomes achieved. The state’s willingness to pay for improving their citizenshealthcare was evaluated ..."
 
Vol 13, No 3 (2020) The evaluation of the balance of standard rates within the program on state guarantees to deliver free medical care to the citizens of the Russian Federation Abstract  similar documents
D. V. Fedyaev, S. A. Kovaleva, K. V. Gerasimova
"... Care to the Citizens of the Russian Federation (PSG) by the parameters approved by the Decree ..."
 
Vol 5, No 1 (2012) COST OF ILLNESS ANALYSIS: TYPES, METHODOLOGY, RUSSIAN SPECIFICS Abstract  similar documents
R. I. Yagudina, I. Yu. Zinchuk, M. M. Litvinenko
"... Cost of illness is one of the basic methods of pharmacoeconomical estimation and in substance ..."
 
Vol 17, No 4 (2024) Development of a classification of anesthetic management methods and protocols for calculating financial costs Abstract  similar documents
D. V. Lukyantseva, J. A. Agafonova, V. V. Omelyanovskiy, S. A. Kovaleva, D. V. Fedyaev, I. N. Pasechnik, V. V. Schukin, D. S. Blinov, A. B. Abrosimov
"... Background. The costs of anesthetic support represent a significant and essential component ..."
 
Vol 17, No 4 (2024) Standardized methodology for calculating the cost of medical care funded by government sources Abstract  similar documents
M. A. Sdvizhkova, S. A. Kovaleva, D. V. Fedyaev, V. V. Omelyanovskiy
"... Background. Current challenges in healthcare include an increase in life expectancy and in medical ..."
 
Vol 17, No 2 (2024) Approaches to determining the cost of laboratory tests Abstract  similar documents
I. I. Khayrullin, V. V. Omelyanovskiy, R. V. Gostishchev, O. A. Sukhorukikh, S. A. Kovaleva, B. G. Gorodetsky
"... Background. Determining the cost of laboratory tests is a significant factor in the context ..."
 
Vol 9, No 4 (2016) FACTORS AND EFFECTS OF PRIVATE HEALTH SPENDING Abstract  similar documents
O. A. Zarubina, N. N. Sisigina
"... health financing policy, significant discretionary (breadth and depth of social healthcare system, public ..."
 
Vol 13, No 4 (2020) Concept of value-based healthcare Abstract  similar documents
N. Z. Musina, V. V. Omelyanovskiy, R. V. Gostischev, O. A. Sukhorukikh, V. K. Fedyaeva, N. N. Sisigina, D. G. Shchurov
"... This article contains the aims and main principles of the concept of value-based healthcare (VBHC ..."
 
Vol 14, No 2 (2021) Organizational and economic aspects of triplet therapy of relapsed/refractory multiple myeloma in the Russian healthcare setting Abstract  similar documents
E. A. Pyadushkina, E. V. Derkach, V. I. Ignatyeva, E. E. Yagnenkova, T. Yu. Klitochenko, T. V. Shelekhova, A. N. Levanov
"... these expensive options can be financially secured remains open. Objective: to assess the cost of triplets ..."
 
Vol 12, No 4 (2019) Evolution of healthcare provider payment mechanisms Abstract  similar documents
V. V. Omelyanovskiy, N. N. Sisigina, V. K. Fedyaeva, N. Z. Musina
"... the elements of cost control with the stimuli that promote a high quality and better access to healthcare ..."
 
Vol 12, No 1 (2019) Individual cost accounting in the management of medical organizations Abstract  similar documents
I. A. Zheleznyakova, L. A. Kovaleva, T. A. Khelisupali
"... In the modern economic conditions, the rational planning of costs and the complex process ..."
 
Vol 5, No 2 (2012) THE ANALYSIS OF COST OF ILLNESS OF PREGNANT WOMEN WITH SYPHILIS Abstract  similar documents
A. I. Ovod, M. D. Mukovnina
 
Vol 10, No 2 (2017) COST-MINIMIZATION OF VILANTEROL / UMECLIDINIUM VERSUS OLODATEROL / TIOTROPIUM IN THE BASIC THERAPY OF SEVERE AND VERY SEVERE COPD Abstract  similar documents
E. G. Kosolapov, F. S. Kochenkov, N. L. Pogudina, D. V. Blinov, N. L. Bondarenko, A. V. Karaulov
"... on COPD treatment costs. Minimizing the costs of highly effective medications is necessary to improve ..."
 
Vol 12, No 3 (2019) Comorbidity in elderly patients with atrial fibrillation affects the “cost of illness” Abstract  similar documents
S. V. Malchikova , N. S. Maksimchuk-Kolobova, M. V. Kazakovtseva 
"... Objective: to analyze whether comorbidity affects the cost of treatment and medical services ..."
 
Vol 9, No 4 (2016) PROPOSALS AND RECOMMENDATIONS FOR OPTIMIZATION OF THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS Abstract  similar documents
D. V. Fedyaev, D. V. Lukyantseva, V. I. Ignatyeva
"... of concretization for formation of State Guarantees fоr free Medical care for Russian Citizen. The proposed ..."
 
Vol 9, No 4 (2016) REVIEW OF PRACTICE AND POSSIBLE DIRECTIONS OF CONCRETIZATION THE PROGRAM OF STATE GUARANTEES FОR FREE MEDICAL CARE FOR RUSSIAN CITIZENS Abstract  similar documents
D. V. Fedyaev, L. S. Melnikova, V. I. Ignatyeva
"... The article describes questions about State Guarantees fоr free Medical care for Russian Citizen ..."
 
Vol 11, No 4 (2018) Clinical and economic studies on pharmacotherapy of malignant neoplasms: the modeling approach Abstract  similar documents
A. G. Tolkushin, S. K. Zyryanov, N. L. Pogudina, M. V. Davydovskaya
"... special attention to the model type, the modeling methodology, information on the effectiveness and cost ..."
 
Vol 13, No 3 (2020) Economic burden of systemic sclerosis: systematic review Abstract  similar documents
D. L. Klabukova, V. S. Krysanova, T. N. Ermolaeva, M. V. Davydovskaya, K. A. Kokushkin
"... on the healthcare system. The difficulties of daily functioning and social adaptation and the overall burden of SSc ..."
 
Vol 13, No 2 (2020) Affordability of in vivo gene therapy. Problems and potential solutions Abstract  similar documents
V. V. Omelyanovskiy, N. Z. Musina, V. A. Lemeshko, A. A. Antonov, F. V. Gorkavenko
"... of healthcare technologies (AHT) and the implemented approaches to the financing of expensive medical ..."
 
Vol 5, No 1 (2012) DYNAMICS OF PREFERENTIAL MAINTENANCE OF CITIZENS WITH ANTIHYPERTENSIVE DRUGS AT THE EXPENSE OF THE REGIONAL BUDGET Abstract  similar documents
I. I. Lavrentyeva, A. I. Khokhlov, I. N. Kagramanyan, T. A. Gorokhova
"... of structure of assortment according to the modern recommendations, essential increase in quantity and cost ..."
 
Vol 16, No 3 (2023) Retrospective pharmacoeconomic study of antibiotic therapy in community-acquired pneumonia Abstract  similar documents
A. A. Taube, T. V. Alexandrova, O. A. Demidova, M. V. Zhuravleva
"... may depend on the age and comorbid conditions of patients. Objective: to analyze the costs ..."
 
Vol 11, No 2 (2018) Clinical and economic efficiency of the loop ileostomy closure by various methods Abstract  similar documents
A. V. Veselov, S. I. Achkasov, O. I. Sushkov, A. I. Moskalev, I. S. Lantsov
"... in the context of optimizing the financial mechanisms of the national healthcare system ..."
 
Vol 10, No 2 (2017) COSTS OF ANTIRETROVIRAL DRUGS USED IN THE THERAPY OF HIV-INFECTED PATIENTS: A PHARMACOECONOMIC ANALYSIS Abstract  similar documents
M. B. Kubaeva, Y. Sh. Guchshina
"... The aim of our study was to conduct a pharmacoeconomic and cost analysis of the therapeutic use ..."
 
Vol 17, No 2 (2024) Methodology of forming a model of diagnosis-related groups for cases of medical care using surgery performed by laparoscopic access Abstract  similar documents
I. A. Zheleznyakova, O. A. Volkova, E. I. Rumiantseva, I. A. Mikhailov, D. V. Fedyaev, A. V. Zuev, O. S. Plakhotnik, G. V. Trifonova, T. S. Vakhrusheva, E. S. Samsonova, V. V. Omelyanovskiy
"... of DRGs in the context of each profile, and calculation of cost-intensity coefficients. Results. Due ..."
 
Vol 11, No 2 (2018) Introduction of medical products into healthcare practice and costs reimbursement: European experience Abstract  similar documents
V. V. Omelyanovsky, S. S. Otstavnov, N. Z. Musina, V. S. Dombrovskii
"... in the present article, we review the ways of introducing medical products into healthcare practice ..."
 
Vol 13, No 4 (2020) Evaluation of the reference value of the incremental parameter "cost-effectiveness" for Russian healthcare system Abstract  similar documents
T. S. Teptsova, N. Z. Musina, V. V. Omelyanovsky
"... Introduction. Presently, the willingness-to-pay threshold (cost-effectiveness threshold ..."
 
Vol 8, No 2 (2015) PHARMACOECONOMIC STUDIES TREATMENT OF PATIENTS WITH INJURIES IN THE DEPARTMENT OF ANESTHESIOLOGY AND RESUSCITATION WITH METHODS ANALYSIS THE COST OF ILLNESS Abstract  similar documents
Anton Alexandrovich Kasatkin
"... of analysis of the cost of the disease, including the payment of medical costs for medical services, medicines ..."
 
Vol 17, No 4 (2024) Pharmacoeconomic analysis of netakimab in the treatment of ankylosing spondylitis: perspective of Russian healthcare system Abstract  similar documents
A. V. Rudakova, I. Z. Gaydukova
"... ensuring cost-effectiveness for the healthcare system along with achieving the efficacy criteria compared ..."
 
Vol 12, No 4 (2019) The health technology assessment system in Australia Abstract  similar documents
V. V. Omelyanovskiy, E. S. Saybel, T. P. Bezdenezhnykh, G. R. Khachatryan
"... the product, assessment of its clinical efficacy, cost-effectiveness analysis, assessment of financial ..."
 
Vol 17, No 1 (2024) Clinical and economic implications of using daratumubab with lenalidomide in the 1st and 2nd lines of therapy for multiple myeloma patients Abstract  similar documents
О. I. Ivakhnenko, V. V. Ryazhenov, N. A. Falaleeva
"... direct healthcare costs and incremental cost-effectiveness ratios (ICERs) per 1 life year gained were ..."
 
Vol 12, No 4 (2019) Crucial areas of the economic analysis of public cancer care Abstract  similar documents
D. A. Andreev, K. I. Polyakova, A. A. Zavyalov, T. N. Ermolaeva, A. G. Fisun, A. D. Ermolaeva, V. A. Dubovtseva, T. E. Maksimova
"... goals of the healthcare system, the cost of cancer treatment should be discussed. The relevant programs ..."
 
Vol 7, No 3 (2014) THE ANALYSIS OF METHODOLOGIC CHARACTERISTICS OF RESEARCHES ON SOCIAL AND ECONOMIC BURDEN OF DISEASES IN RUSSIA IN THE FRAMES OF DEVELOPMENT OF STANDARD COST OF ILLNESS METHODOLOGY FOR THE HEALTH TECHNOLOGY ASSESSMENT Abstract  similar documents
V. I. Ignatyeva, M. V. Avxentyeva
"... there are no uninamioulsly accepted methods and approaches for this type of research. The cost of illness method (assessment ..."
 
Vol 13, No 4 (2020) The social-economic burden of spinal muscular atrophy in Russia Abstract  similar documents
A. S. Kolbin, D. V. Vlodavets, A. A. Kurylev, Yu. Ye. Balykina, M. A. Proskurin, S. A. Mishinova, O. Yu. Germanenko, N. Yu. Kolbina
"... (medical, social etc.) throughout their life and the cost of the care has never been calculated in Russia ..."
 
Vol 9, No 2 (2016) METASTATIC COLORECTAL TREATMENT COSTS OF USING TARGETED DRUGS IN SECOND AND FURTHER LINES THERAPY Abstract  similar documents
N. A. Avxentyev, E. V. Derkach, E. A. Pyadushkina, M. D. Ter-Ovanesov
"... of this study is to compare costs associated with these options in Russia. Materials and methods. We calculated ..."
 
Vol 15, No 2 (2022) Pharmacoeconomic study of the treatment of arterial hypertension in children and adolescents using cost-of-illness analysis Abstract  similar documents
O. S. Mikhaylova, A. V. Krikova
"... Background. The cost-of-illness (COI) analysis allows to estimate and plan costs for calculations ..."
 
Vol 14, No 1 (2021) Analysis of acquisition and the monthly cost of antihypertensive therapy with modern fixed-dose combinations in the Far Eastern Federal District Abstract  similar documents
M. S. Soboleva, E. E. Loskutova
"... Objective: analyzing the acquisition and monthly costs for patients on modern fixed-dose ..."
 
Vol 12, No 1 (2019) Economic consequences of healthcare optimization for IBD patients in the Republic of Tatarstan Abstract  similar documents
T. P. Bezdenezhnykh, D. V. Fedyaev, G. R. Khachatryan, G. G. Arutyunov, K. V. Gerasimova
"... costs. The present study aims to assess the economic consequences of the proposed IBD healthcare ..."
 
Vol 11, No 2 (2018) Economic evaluation of postoperative hypofractionated radiation therapy in patients with breast cancer Abstract  similar documents
G. V. Afonin, Yu. A. Ragulin, M. V. Avxentyeva, I. A. Gulidov, S. A. Ivanov, A. D. Kaprin
"... the treatment costs in patients with breast cancer while maintaining a high treatment efficacy and quality ..."
 
Vol 13, No 4 (2020) Evaluation of the economic effect of biological therapy in patients with severe COVID-19 and cytokine storm Abstract  similar documents
M. Yu. Frolov, A. S. Salasyuk, V. A. Rogov
"... using the cost of illness analysis in a model developed in Microsoft Excel 2016 (Microsoft, USA ..."
 
Vol 14, No 2 (2021) Pharmacoeconomic aspects of the therapy for moderate and severe psoriatic arthritis Abstract  similar documents
A. V. Rudakova, D. G. Tolkacheva, V. D. Sokolova
"... for PsA on the budget of the Russian healthcare system. Material and methods. The evaluation of cost ..."
 
Vol 15, No 1 (2022) Cost-effectiveness and budget impact analyses of using implantable cardioverter-defibrillators in the Russian Federation Abstract  similar documents
T. O. Bessonova, F. V. Gorkavenko, D. G. Shchurov, Yu. V. Seryapina, O. R. Chetverikova, V. V. Omelyanovskiy, S. N. Krivolapov, N. M. Neminushchiy, A. A. Kalemberg
"... to the healthcare system of the Russian Federation (RF). The main scenario accounted for ICD implantation cost ..."
 
Vol 16, No 4 (2023) Analysis of the clinical and economic effectiveness of using benralizumab in comparison with standard therapy in patients with severe bronchial asthma Abstract  similar documents
S. V. Nedogoda, A. S. Salasyuk, S. N. Avdeev, I. N. Barykina, V. O. Lutova, E. A. Popova
"... adapted to the Russian healthcare conditions with the help of cost indicators and patient population ..."
 
Vol 9, No 1 (2016) COST-EFFECTIVENESS ANALYSIS OF BRENTUXIMAB VEDOTIN IN ADULTS WITH RELAPSED OR REFRACTORY HODGKIN’S LYMPHOMA Abstract  similar documents
G. R. Khachatryan, D. V. Fedyaev, M. V. Avxentyeva, V. S. Dombrovskiy
"... healthcare system point of view. Incremental cost-effectiveness ratio (ICER) for BV vs Ch ± RT and Ch ± RT ..."
 
Vol 18, No 1 (2025) Pharmacoeconomic analysis of lanreotide and prolonged-release octreotide in first- and second-line therapy of acromegaly Abstract  similar documents
I. S. Krysanov, E. V. Makarova, V. Yu. Ermakova, D. V. Kurkin
"... is a clinically and cost-effective approach in the context of the Russian healthcare system. ..."
 
Vol 10, No 3 (2017) Comparative pharmaco-economic analysis of using enzalutamide, abiraterone and cabazitaxel in post-docetaxel castration-resistant prostate cancer patients Abstract  similar documents
N. K. Mazina, P. V. Mazin
"... with increasing expenses and thus impacts the healthcare budgets at various levels. The aim was to study ..."
 
Vol 14, No 3 (2021) Review of methods for planning the scope of medical care and financing of the healthcare system by the subjects of the Russian Federation Abstract  similar documents
S. A. Kovaleva, D. V. Fedyaev, N. N. Sisigina
 
Vol 8, No 4 (2015) THE COST OF NUTRITION ALTERNATIVES FOR PREMATURE INFANTS IN RUSSIA Abstract  similar documents
K. V. Gerasimova, M. V. Avxentyeva, I. A. Belyaeva
"... breastfeeding. Methods. The cost of providing 100 ml of breast milk (BM) using clinical breast pump and 100 ml ..."
 
Vol 16, No 3 (2023) Efficacy of alectinib in comparison with lorlatinib in patients with ALK-positive non-small cell lung cancer: pharmacoeconomic study Abstract  similar documents
A. S. Kolbin, Yu. M. Gomon, M. A. Proskurin, Yu. E. Balykina
"... cancer (NSCLC). Materials and methods. The calculations included the direct costs of the healthcare ..."
 
1 - 50 of 282 Items 1 2 3 4 5 6 > >> 

Search tips:

  • Search terms are case-insensitive
  • Common words are ignored
  • By default articles containing any term in the query are returned (i.e., OR is implied)
  • Make sure that a word exists in an article by prefixing it with +; e.g., +journal +access scholarly academic
  • Combine multiple words with AND to find articles containing all terms; e.g., education AND research
  • Exclude a word by prefixing it with - or NOT; e.g., online -politics or online NOT politics
  • Search for an exact phrase by putting it in quotes; e.g., "open access publishing". Hint: Quoting Chinese or Japanese words will help you to find exact word matches in mixed-language fields, e.g. "中国".
  • Use parentheses to create more complex queries; e.g., archive ((journal AND conference) NOT theses)